Q-omics provides the consensus-scored RNU6-622P profile across patient tissues and cancer cell-line models. RNU6-622P expression is associated with patient survival in 6 of 34 cancer types, with the highest sampling consensus in STAD. Additionally, RNU6-622P RNA expression shows 8,578 significant gene co-expression associations, with the highest sampling consensus in LUSC. Together, these results highlight STAD, and LUSC as cancer lineages where RNU6-622P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for RNU6-622P — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes RNU6-622P survival associations across molecular data types. RNU6-622P RNA expression shows survival associations in the most cancer types (6). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

RNU6-622P data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	6	STAD (75)	view →

This table ranks reproducible RNU6-622P RNA expression–survival associations across cancer types. High RNU6-622P expression shows unfavorable associations in KICH, KIRC, UCEC, KIRP and BLCA, but favorable associations in STAD. The STAD Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p = .005). Together, the overview and detailed table identify STAD as the clearest survival context for RNU6-622P RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	III,IV	0.945	0.536	.005	75	view →
KICH	DFS	Tertile	All	0.102	0.848	.004	39	view →
KIRC	DFS	Tertile	IV	0.109	0.640	<.001	36	view →
UCEC	OS	Tertile	III,IV	0.303	0.594	.032	18	view →
KIRP	OS	Tertile	All	0.187	0.708	.002	12	view →
BLCA	DFS	Tertile	III,IV	0.159	0.572	.036	9	view →

Pink = unfavorable, green = favorable. all 6 lineages →

RNU6-622P-STAD (DFS)

Kaplan–Meier survival curve for RNU6-622P RNA expression in STAD: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with RNU6-622P in patient tissues and cancer cell lines. In patient samples, RNU6-622P shows the broadest associations at the RNA and protein expression levels, with LUSC recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
RNA	8,578	LUSC (4534)	view →
Function (RNA)	6,224	STAD (5953)	view →